Global /Taiwan /Industrials /Specialty Business Services /7427

Great Novel Therapeutics Biotech & Medicals

7427

• TPEX: 7427 • Delayed

42.15TWD 5.1%

1.33 USD

As of 23 June 2026, Great Novel Therapeutics Biotech & Medicals has a market cap of $54.32M USD, ranking #30002 globally and #1791 in Taiwan. It ranks #6846 in the Industrials sector, and #789 in the Specialty Business Services industry.

Global Rank

30002

Country Rank

1791

Sector Rank

6846

Industry Rank

789

Key Stats

Market Cap

$54.32MUSD

1.72B TWD

Enterprise Value

$40.53MUSD

1.28B TWD

Revenue (TTM)

$38.0KUSD

1.21M TWD

EBITDA (TTM)

-$2.9MUSD

-91.86M TWD

Net Income (TTM)

-$3.07MUSD

-97.47M TWD

PS Ratio

1429.3

PB Ratio

3.4

Company Profile

Country (HQ)

Taiwan

Sector

Industrials

Industry

Specialty Business Services

CEO

Chia-Nan Chen open_in_new

Employees

Founded

2013

Website

gntbm.com.tw open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
5.1%	-9.2%	30%	7.7%	25%	25%	2.4%	-56%	36%

News

Markets

Exchange	Ticker	Price	Quotes
Taipei Exchange (TPEX) MIC: ROCO PRIMARY	7427 華上生技醫藥股份有限公司 ISIN: TW0007427007 Shares Out.: Shares Outstanding: 45.286M¹ TV: TradingView: TPEX: 7427 SA: Stock Analysis: TPEX: 7427 YF: Yahoo Finance: 7427.TWO GF: Google Finance: TPEX: 7427 BA: Barron's: 7427 MS: Morningstar: ROCO: 7427	42.15 TWD	TV: TradingView: TPEX: 7427 SA: Stock Analysis: TPEX: 7427 YF: Yahoo Finance: 7427.TWO GF: Google Finance: TPEX: 7427 BA: Barron's: 7427 MS: Morningstar: ROCO: 7427

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Great Novel Therapeutics Biotech & Medicals

Great Novel Therapeutics Biotech & Medicals engages in the development of drugs for the treatment of advanced and refractory cancers. The company develops drugs for cancer immunotherapy, including tumor microenvironment regulators, epigenetic immunoactivators, and immune-regulating multi-kinase inhibitors. The company was formerly known as GNT Biotech & Medicals Corporation. Great Novel Therapeutics Biotech & Medicals was founded in 2013 and is based in Taipei, Taiwan.

Similar Companies

Industry: Specialty Business Services (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
King Yuan Electronics Co., Ltd. TWSE: 2449	$10.93B 346.65B TWD 20K%	43.7	Taiwan
Ardentec Corp. TPEX: 3264	$2.98B 94.55B TWD 5K%	33.6	Taiwan
Sigurd Microelectronics Corp. TWSE: 6257	$2.68B 84.98B TWD 5K%	31.1	Taiwan
Heron Neutron Medical Corp. TWSE: 7799	$1.9B 60.17B TWD 3K%	-	Taiwan
Taiwan Secom Co., Ltd. TWSE: 9917	$1.6B 50.84B TWD 3K%	16.9	Taiwan
Foxtron Vehicle Technologies Co., Ltd. TWSE: 2258	$1.57B 49.77B TWD 3K%	-	Taiwan

Industry: Specialty Business Services (Global)

Name	Market Cap (USD) diff.	PE	Country
Shopify Inc. NASDAQ: SHOP	$158.14B 291K%	129.8	Canada
Verisure plc STO: VSURE	$131.7B 114.8B EUR 242K%	-	United Kingdom
Cintas Corp. NASDAQ: CTAS	$69.6B 128K%	36.8	United States
RELX PLC LSE: REL	$63.18B 47.6B GBP 116K%	23.9	United Kingdom
PayPal Holdings, Inc. NASDAQ: PYPL	$45.83B 84K%	9.4	United States
T Thomson Reuters Corp. NEO: TRI	$41.8B 56.91B CAD 77K%	-	Canada

chevron_leftBack